FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247306175> ?p ?o ?g. }

• W4247306175 endingPage "856" @default.
• W4247306175 startingPage "849" @default.
• W4247306175 abstract "Myeloid leukemia cells, the human promyelocytic cell line HL-60, and a subpopulation of normal marrow cells produce a leukemia-associated inhibitor (LAI) that reversibly downmodulates DNA synthesis of normal granulopoietic progenitor cells colony-forming unit granulocyte-macrophage (CFU-GM). We isolated an active 125-kD component of LAI from HL-60 conditioned medium (CM), subjected it to cyanogen bromide cleavage and show by amino acid sequencing of the resulting peptides that it consists of a complex of the serine proteinase inhibitor 1-antitrypsin and a 31-kD fragment that retained the S-phase inhibitory activity, but resisted sequencing. This finding suggested that the 31-kD fragment originated from one of the neutrophil serine proteases (ie, elastase, proteinase 3, or cathepsin G) produced by normal promyelocytes, as well as HL-60 cells, for storage in primary granules and partly secreted during synthesis as enzymatically inactive proforms. Immunoblot analysis showed that the 125-kD complex contained proteinase 3 (PR3), and immunoprecipitation of PR3 from HL-60 CM abrogated the S-phase inhibitory activity, whereas immunoprecipitation of cathepsin G or elastase did not. Immunoprecipitation of PR3 from CM of a subpopulation of normal marrow cells also abrogated the S-phase inhibitory effect. Furthermore, CM from rat RBL and murine 32D cell lines transfected with human PR3 both reduced the fraction of CFU-GM in S-phase with 30% to 80% at 1 to 35 ng/mL PR3, whereas CM of the same cells transfected with cathepsin G or elastase did not. Also, an enzymatically silent mutant of PR3 exerted full activity, showing that the S-phase modulatory effect is not dependent on proteolytic activity. Amino acid sequencing of biosynthetically radiolabeled PR3 showed that PR3 from transfected cells is secreted after synthesis as proforms retaining amino terminal propeptides. In contrast, mature PR3 extracted from mature neutrophils has only minor activity. The inhibitory effect of secreted PR3 is reversible and abrogated by granulocyte (G)- or granulocyte-macrophage colony-stimulating factor (GM-CSF). Experiments with highly purified CD34+ bone marrow cells suggested that PR3 acts directly on the granulopoietic progenitor cells. These observations suggest a role for PR3 in regulation of granulopoiesis, and possibly in suppression of normal granulopoiesis in leukemia." @default.
• W4247306175 created "2022-05-12" @default.
• W4247306175 creator A5038271400 @default.
• W4247306175 creator A5038829375 @default.
• W4247306175 creator A5048477413 @default.
• W4247306175 creator A5052942000 @default.
• W4247306175 date "1999-02-01" @default.
• W4247306175 modified "2023-10-16" @default.
• W4247306175 title "A Secreted Proform of Neutrophil Proteinase 3 Regulates the Proliferation of Granulopoietic Progenitor Cells" @default.
• W4247306175 cites W1518605826 @default.
• W4247306175 cites W1523740849 @default.
• W4247306175 cites W1564179195 @default.
• W4247306175 cites W1597610606 @default.
• W4247306175 cites W1599512009 @default.
• W4247306175 cites W1708784406 @default.
• W4247306175 cites W1966999651 @default.
• W4247306175 cites W1972136521 @default.
• W4247306175 cites W1973784016 @default.
• W4247306175 cites W1980079864 @default.
• W4247306175 cites W1981156327 @default.
• W4247306175 cites W1982679047 @default.
• W4247306175 cites W1982973008 @default.
• W4247306175 cites W2003398489 @default.
• W4247306175 cites W2004696880 @default.
• W4247306175 cites W2010431625 @default.
• W4247306175 cites W2019037616 @default.
• W4247306175 cites W2028274030 @default.
• W4247306175 cites W2060913542 @default.
• W4247306175 cites W2069063580 @default.
• W4247306175 cites W2071558773 @default.
• W4247306175 cites W2080822994 @default.
• W4247306175 cites W2085686483 @default.
• W4247306175 cites W2100266174 @default.
• W4247306175 cites W2111633442 @default.
• W4247306175 cites W2114302525 @default.
• W4247306175 cites W2301167541 @default.
• W4247306175 cites W2344615469 @default.
• W4247306175 cites W2500742995 @default.
• W4247306175 cites W4232680378 @default.
• W4247306175 cites W4234465668 @default.
• W4247306175 cites W4237851084 @default.
• W4247306175 doi "https://doi.org/10.1182/blood.v93.3.849.403k07_849_856" @default.
• W4247306175 hasPublicationYear "1999" @default.
• W4247306175 type Work @default.
• W4247306175 citedByCount "6" @default.
• W4247306175 crossrefType "journal-article" @default.
• W4247306175 hasAuthorship W4247306175A5038271400 @default.
• W4247306175 hasAuthorship W4247306175A5038829375 @default.
• W4247306175 hasAuthorship W4247306175A5048477413 @default.
• W4247306175 hasAuthorship W4247306175A5052942000 @default.
• W4247306175 hasConcept C153911025 @default.
• W4247306175 hasConcept C167844969 @default.
• W4247306175 hasConcept C181199279 @default.
• W4247306175 hasConcept C185592680 @default.
• W4247306175 hasConcept C201750760 @default.
• W4247306175 hasConcept C203014093 @default.
• W4247306175 hasConcept C203565725 @default.
• W4247306175 hasConcept C21194631 @default.
• W4247306175 hasConcept C2776317360 @default.
• W4247306175 hasConcept C2776414213 @default.
• W4247306175 hasConcept C2776914184 @default.
• W4247306175 hasConcept C2777132095 @default.
• W4247306175 hasConcept C2781044401 @default.
• W4247306175 hasConcept C28328180 @default.
• W4247306175 hasConcept C54009773 @default.
• W4247306175 hasConcept C54355233 @default.
• W4247306175 hasConcept C55493867 @default.
• W4247306175 hasConcept C71829478 @default.
• W4247306175 hasConcept C81885089 @default.
• W4247306175 hasConcept C86803240 @default.
• W4247306175 hasConcept C95444343 @default.
• W4247306175 hasConceptScore W4247306175C153911025 @default.
• W4247306175 hasConceptScore W4247306175C167844969 @default.
• W4247306175 hasConceptScore W4247306175C181199279 @default.
• W4247306175 hasConceptScore W4247306175C185592680 @default.
• W4247306175 hasConceptScore W4247306175C201750760 @default.
• W4247306175 hasConceptScore W4247306175C203014093 @default.
• W4247306175 hasConceptScore W4247306175C203565725 @default.
• W4247306175 hasConceptScore W4247306175C21194631 @default.
• W4247306175 hasConceptScore W4247306175C2776317360 @default.
• W4247306175 hasConceptScore W4247306175C2776414213 @default.
• W4247306175 hasConceptScore W4247306175C2776914184 @default.
• W4247306175 hasConceptScore W4247306175C2777132095 @default.
• W4247306175 hasConceptScore W4247306175C2781044401 @default.
• W4247306175 hasConceptScore W4247306175C28328180 @default.
• W4247306175 hasConceptScore W4247306175C54009773 @default.
• W4247306175 hasConceptScore W4247306175C54355233 @default.
• W4247306175 hasConceptScore W4247306175C55493867 @default.
• W4247306175 hasConceptScore W4247306175C71829478 @default.
• W4247306175 hasConceptScore W4247306175C81885089 @default.
• W4247306175 hasConceptScore W4247306175C86803240 @default.
• W4247306175 hasConceptScore W4247306175C95444343 @default.
• W4247306175 hasIssue "3" @default.
• W4247306175 hasLocation W42473061751 @default.
• W4247306175 hasOpenAccess W4247306175 @default.
• W4247306175 hasPrimaryLocation W42473061751 @default.
• W4247306175 hasRelatedWork W1982642758 @default.
• W4247306175 hasRelatedWork W2004920855 @default.

• next